This
announcement contains inside information for the purposes of the UK
Market Abuse Regulation and the Directors of the Company are
responsible for the release of this announcement.
31
January
2025
ChallengerX
plc
(“ChallengerX”,
“CX" or
the
"Company")
Management
accounts for the
quarters ended
31 December 2024 and
30 September 2024
ChallengerX
(AQUIS:
CXS)
announces
its unaudited management accounts reports for the quarters ended
31 December 2024 and 30 September 2024.
For
further
information,
please
contact:
ChallengerX
plc
|
|
|
John May,
Chairman
|
|
jmay@city-westminster.com
|
Stuart
Adam, CFO
|
|
sjadam@city-westminster.com
|
Directors
Statement
Introduction
ChallengerX
plc (the “Company” or “ChallengerX”) is quoted on the Aquis Stock
Exchange (“AQSE”) Growth Market. The Company was
incorporated on
7
June
2021
and
its
shares
were
admitted
to
trading
on
23
December
2021.
Trading in
the Company's ordinary shares on AQSE was suspended on 6 June 2024.
The
Company is aware of its continuing obligations under the AQSE
rules.
Activities
during
the
periods
The
Company was in negotiations to complete a significant transaction
for the Company; it was also reviewing other
products to add to its core business. The Company’s aim is to
enhance its position and seek to restore its shares to trading as
soon as possible.
Outlook
On 8
January the Company announced it had raised a total of £120,000
through the issuance of a Convertible Loan Note. The Loan will be
automatically converted into 120,000,000 ordinary shares of £0.001
each in the Company upon the relisting of ChallengerX Shares on the
Aquis Stock Exchange.
On 20
January the Company further announced it is in active negotiations
with the owners of Nyce International Limited and Virya VC Limited,
with the aim to acquire their entire issued share capital. In
addition, as part of this transaction, the Company announced the
intention to enter into a licensing agreement in relation to an
instance of Reelsoft AB’s Vision RGS (Remote Gaming Server) and
Game Aggregation Platform (together, the "Potential
Acquisitions").
The
Company is at an advanced stage of its legal and financial due
diligence process and negotiation of the share purchase agreements
and licensing agreements. A significant part of the costs
associated with this process have been included in expenditure to
31 December 2024.
The Board
is also negotiating certain new board appointments and working
alongside an Aquis Corporate Adviser to conduct a review of the
potential candidates’ experience and background as well as of the
enlarged group’s suitability, following completion of the Potential
Acquisitions and readmission to trading on the Aquis Stock
Exchange.
It is not
expected that the Potential Acquisitions would constitute a Reverse
Takeover under Rule 3.6 of the Access Rulebook.
The
Potential Acquisitions are subject to a number of conditions,
including the lifting of the suspension to trading of ChallengerX
Shares by Aquis Stock Exchange, the issue and admission of the new
Ordinary Shares to trading, and completion of a fundraise in a
sufficient amount to satisfy the enlarged group’s working capital
requirement.
The
completion of the Potential Acquisitions and relisting of
ChallengerX Shares on the Aquis Stock Exchange cannot be
guaranteed.
John May
Chairman
Statement
of Comprehensive Income for the
quarters
ended
31 December 2024 and
30
September 2024
|
31
December
2024
|
30
September
2024
|
|
£’000
|
£’000
|
Revenue
|
-
|
-
|
Administrative
expenses
|
(121)
|
(46)
|
Operating
loss
|
(121)
|
(46)
|
Loss
before
tax
|
(121)
|
(46)
|
Taxation
|
-
|
-
|
Loss
for
the
period
|
(121)
|
(46)
|
Total
comprehensive
loss
|
(121)
|
(46)
|
(Loss)
per
share
(pence)
from
continuing
operations
attributable
to
owners
of
the
Company
–
Basic
and diluted earnings per share
|
(0.028)
|
(0.011)
|
Statement
of Financial Position as at quarters ended 31 December 2024 and 30
September 2024
|
31
December
2024
£’000
|
30
September
2024
(restated)
£’000
|
Intangible
assets
|
|
|
Software
Licence
|
-
|
-
|
Current
assets
|
|
|
Trade
and
other
receivables
|
16
|
4
|
Cash
and
cash
equivalents
|
103
|
1
|
Total
current
assets
|
119
|
5
|
Total
assets
|
119
|
5
|
Current
liabilities
|
|
|
Trade
and
other
payables
|
473
|
238
|
Total
current
liabilities
|
473
|
238
|
Net
assets
|
(354)
|
(233)
|
Capital
and
reserves
|
|
|
Share
capital:
-
Issued
-
Treasury
|
432
1
|
432
1
|
Total
share capital
|
433
|
433
|
Share
premium
|
1,786
|
1,786
|
Retained
earnings
|
(2,573)
|
(2,452)
|
Total
equity
|
(354)
|
(233)
|
Statement
of
Changes
in
Equity
For
the
quarters
ended
31 December 2024 and
30 September 2024
|
Share
capital
|
Share premium
|
Retained earnings
|
Total
|
|
£’000
|
£’000
|
£’000
|
£’000
|
As
at 30 June 2024 (restated)
|
433
|
1,786
|
(2,406)
|
(187)
|
Issue of share capital
|
-
|
-
|
-
|
-
|
Loss for the quarter ended 30 September 2024
|
-
|
-
|
(46)
|
(46)
|
Total
Comprehensive
Income
|
-
|
-
|
(46)
|
(46)
|
As
at
30
September 2024
|
433
|
1,786
|
(2,452)
|
(233)
|
Issue of share capital
|
-
|
-
|
-
|
-
|
Loss for the quarter ended 31 December 2024
|
-
|
-
|
(121)
|
(121)
|
Total
Comprehensive
Income
|
-
|
-
|
(121)
|
(121)
|
As
at
31
December 2024
|
433
|
1,786
|
(2,573)
|
(354)
|
Statement
of
Cash
Flows
For
the
quarters ended 31 December
2024
and 30 September
2024
|
31 December 2024
|
30 September
2024
|
|
£’000
|
£’000
|
Cash
from
operating
activities
|
|
|
Loss
before
tax
|
(121)
|
(46)
|
Adjustments
for:
|
|
|
(Increase)/decrease
in trade
and
other
receivables
|
(12)
|
3
|
Increase
/(decrease) in trade
and
other
payables
|
115
|
42
|
Net
cash
(used)
in
operating
activities
|
(18)
|
(1)
|
Cash
flows from financing activities
|
|
|
Issue of
share capital
|
-
|
-
|
Adjustment
to share premium
|
-
|
-
|
Loan
received
|
120
|
-
|
Net
cash
from
financing
activities
|
120
|
-
|
Net
cash
flow
for
the
period
|
102
|
(1)
|
Cash
and
cash
equivalents
at
beginning
of
period
|
1
|
2
|
Cash
and
cash
equivalents
at
end
of
period
|
103
|
1
|
Net
change
in
cash
and
cash
equivalents
|
103
|
(1)
|
Cash
and
cash
equivalents
comprise:
|
|
|
Cash
at
bank
and
in
hand
|
103
|
1
|
|
103
|
1
|
Notes
to
the
financial
statements
-
General
information
ChallengerX
plc
is
a
public
limited
company
limited
by
shares
and
was
incorporated
in
England on
7 June 2021 with company number 13440398. Its registered
office is 16 Great Queen Street, London, WC2B 5DG.
The
Company’s
shares
are
currently suspended from trading
on
the
Aquis
Stock
Exchange
Growth
Market
under
symbol CXS
and
ISIN
number GB00BMD0WG01.
The
Company
was
first
incorporated
on
7
June 2021.
The information for periods ended 31
December 2024 and 30 September
2024 are unaudited.
-
Basis
of
Preparation
The
quarterly management accounts of ChallengerX plc have been prepared
in compliance with United Kingdom Accounting Standards,
including
Financial
Reporting
Standard
102,
“The
Financial
Reporting
Standard
applicable
in the United Kingdom and the
Republic of Ireland” (“FRS 102”) and the Companies Act
2006.
These
management
accounts are
prepared
on
a
going
concern
basis,
under
the
historical
cost
convention.
The
financial
statements
are
presented
in
Pounds
Sterling,
which
is
the
Company’s
presentation
and
functional
currency.
The
preparation of the financial statements requires the use of certain
critical accounting estimates. It also requires management to
exercise its judgment in the process of applying the Company’s
accounting policies.
The
financial
statements
have
been
prepared
on
the
historical
cost
basis
and
are
presented
in
£’000
unless
otherwise
stated.
-
Going
Concern
As at
31 December 2024, the Company had
cash of £103,341. The Company has limited operating
cash
flow
and
is
dependent
on
the
performance
of
its
trading
and its
cash
balances
for
its
working capital requirements. As at the date of this report, the
Company had approximately £78,327 cash at bank.
In making
their assessment of going concern, the Directors, having made due
and careful enquiry, are of the opinion that the Company will have
access to adequate working capital to meet its obligations for the
period of at least 12 months from the date these management
accounts are authorized for issue. The Directors,
have
discussed
the Company's position with its investors and potential investors
and believes it will secure the funding required to pursue its
objectives.
The
Directors believe in the Company’s potential. However, the success
of securing funding has been identified as a material uncertainty
which may cast significant doubt over the going concern assessment.
Whilst acknowledging this uncertainty, based upon the expectation
of completing a successful fundraising in the near future, and the
continued support of its investors, the Directors consider it
appropriate to continue to prepare the financial statements on a
going concern basis.
-
Earnings
per
share
|
31 December 2024
|
30 September 2024
|
Earnings
|
£’000
|
£’000
|
Loss
for
the
quarters ended
|
(121)
|
(46)
|
Number
of
shares
|
|
|
Number of
shares for the purposes of basic and diluted earnings per
share
|
432,580,556
|
432,580,556
|
Earnings
per
share
(pence)
|
(0.028)
|
(0.011)
|